Furthermore, Song et al., discovered that 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment significantly up-regulates ACSL4 expression and down-regulates GPX4 expression in PD mice (Table 1). The gene discussed is ACSL4; the disease is Parkinson disease.